Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
SUNPHARMA.NS
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q1.23
N/A
8.27
vs NA
Q2.23
N/A
9.9
vs NA
Q3.23
+12%
10.52
vs 9.4
Q4.23
0%
9.01
vs 9.03
Q1.24
N/A
NA
vs 8.27
Q2.24
N/A
9.9
vs 9.9
Q3.24
0%
10.5
vs 10.52
Q4.24
+28%
11.53
vs 9.01
Q1.25
N/A
9.96
vs NA
Q2.25
+6%
10.51
vs 9.9
Sales Growth
YoY
Current
Estimates
Q1.23
+14%
107.3B vs 93.9B
Q2.23
+11%
117.9B vs 106.4B
Q3.23
+11%
120B vs 108.1B
Q4.23
+10%
121.6B vs 111B
Q1.24
+12%
119.8B vs 107.3B
Q2.24
+7%
126.5B vs 117.9B
Q3.24
+11%
132.9B vs 120B
Q4.24
+11%
134.4B vs 121.6B
Q1.25
+2%
122.3B vs 119.8B
Q2.25
+2%
128.8B vs 126.5B
Return on Equity
QoQ
Q1.23
+4%
0.04
vs 0.04
Q2.23
+3%
0.03
vs 0.04
Q3.23
+4%
0.04
vs 0.03
Q4.23
+4%
0.04
vs 0.04
Q1.24
+4%
0.04
vs 0.04
Q2.24
+4%
0.04
vs 0.04
Q3.24
+4%
0.04
vs 0.04
Q4.24
NA
NA
vs 0.04
Institutionnal Ownership
Relative Strength
SUNPHARMA.NS
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|
Quote Panel
Key Metrics
Forecast
2025-Revenue
2025-EPS
2025-EBITDA
Analyst rating
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How SUNPHARMA.NS compares to sector?